+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Osteoarthritis Therapeutics Market 2019-2023 - Product Image

Global Osteoarthritis Therapeutics Market 2019-2023

  • ID: 4764951
  • Report
  • Region: Global
  • 125 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi
  • MORE
The increasing incidence of osteoarthritis will drive the osteoarthritis therapeutics market growth in the forthcoming years. Rising incidences of aging and obesity will directly contribute to the increasing prevalence of osteoarthritis in both developing and developed regions. Furthermore, the inflammation of adipose tissue and dyslipidemia associated with obesity is further expected to contribute majorly to the osteoarthritis therapeutics market growth in the forthcoming years. The analysts have predicted that the osteoarthritis therapeutics market will register a CAGR of about 8% by 2023.

Market Overview

Availability of guidelines for disease management

One of the growth drivers of the global osteoarthritis therapeutics market is the availability of guidelines for disease management. This will improvise the patient acceptance of drugs, which, in turn, is expected to drive the market growth.

Side-effects of available drugs

One of the challenges in the growth of the global osteoarthritis therapeutics market is the side-effects of available drugs. The common side-effects associated with available drugs such as constipation, physical dependence, and numbness can limit the adoption of the available drugs.

For the detailed list of factors that will drive and challenge the growth of the osteoarthritis therapeutics market during 2019-2023, view this report.

Competitive Landscape

The market appears to be moderately concentrated with the presence of a few market players. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Analgesics and NSAIDs - Market size and forecast 2018-2023
  • Corticosteriods - Market size and forecast 2018-2023
  • Viscosupplements - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TYPE
  • Ankle osteoarthritis
  • Hip osteoarthritis
  • Knee osteoarthritis
  • Shoulder osteoarthritis
  • Others
PART 10: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Sanofi
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pipeline molecules for osteoarthritis
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Analgesics and NSAIDs - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Analgesics and NSAIDs - Year-over-year growth 2019-2023 (%)
Exhibit 22: Corticosteriods - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Corticosteriods - Year-over-year growth 2019-2023 (%)
Exhibit 24: Viscosupplements - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Viscosupplements - Year-over-year growth 2019-2023 (%)
Exhibit 26: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Others - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Bayer AG - Vendor overview
Exhibit 49: Bayer AG - Business segments
Exhibit 50: Bayer AG - Organizational developments
Exhibit 51: Bayer AG - Geographic focus
Exhibit 52: Bayer AG - Segment focus
Exhibit 53: Bayer AG - Key offerings
Exhibit 54: GlaxoSmithKline plc - Vendor overview
Exhibit 55: GlaxoSmithKline plc - Business segments
Exhibit 56: GlaxoSmithKline plc - Organizational developments
Exhibit 57: GlaxoSmithKline plc - Geographic focus
Exhibit 58: GlaxoSmithKline plc - Segment focus
Exhibit 59: GlaxoSmithKline plc - Key offerings
Exhibit 60: Johnson & Johnson Services, Inc. - Vendor overview
Exhibit 61: Johnson & Johnson Services, Inc. - Business segments
Exhibit 62: Johnson & Johnson Services, Inc. - Organizational developments
Exhibit 63: Johnson & Johnson Services, Inc. - Geographic focus
Exhibit 64: Johnson & Johnson Services, Inc. - Segment focus
Exhibit 65: Johnson & Johnson Services, Inc. - Key offerings
Exhibit 66: Pfizer Inc. - Vendor overview
Exhibit 67: Pfizer Inc. - Business segments
Exhibit 68: Pfizer Inc. - Organizational developments
Exhibit 69: Pfizer Inc. - Geographic focus
Exhibit 70: Pfizer Inc. - Segment focus
Exhibit 71: Pfizer Inc. - Key offerings
Exhibit 72: Sanofi - Vendor overview
Exhibit 73: Sanofi - Business segments
Exhibit 74: Sanofi - Organizational developments
Exhibit 75: Sanofi - Geographic focus
Exhibit 76: Sanofi - Segment focus
Exhibit 77: Sanofi - Key offerings
Exhibit 78: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi
  • MORE
Global Osteoarthritis Therapeutics Market 2019-2023

The analyst recognizes the following companies as the key players in the global osteoarthritis therapeutics market: Bayer AG, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Pfizer Inc., and Sanofi.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the advancements in gene therapy and biotherapy.”

According to the report, one of the major drivers for this market is the availability of improved diagnostic modalities.

Further, the report states that one of the major factors hindering the growth of this market is the side-effects of available drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll